Amanta Healthcare Ltd (AMANTA)
🎯 Key Takeaways
- Revenue declined 10.6% QoQ to ₹69 in Q1FY27.
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 71 | 74 | 77 | 69 |
| Operating Profit | 10 | 11 | 10 | 10 |
| OPM % | 14.1% | 14.3% | 13.3% | 14.3% |
| Net Profit | 1 | 5 | 6 | 3 |
| EPS | ₹0.35 | ₹1.35 | ₹1.61 | ₹0.85 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 29 | 39 | 39 |
| Reserves | 68 | 172 | 181 |
| Borrowings | 195 | 186 | 244 |
| Total Liabilities | 382 | 488 | 558 |
| Fixed Assets | 217 | 209 | 206 |
| Investments | 8 | 8 | 7 |
| Total Assets | 382 | 488 | 558 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +47 |
| Investing | -24 |
| Financing | -23 |
| Net Cash Flow | -1 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 63.6% | 63.6% | 63.7% | 63.8% |
| FII | 1.0% | 1.1% | 0.8% | 0.4% |
| DII | 11.3% | 11.2% | 12.9% | 12.9% |
| Public | 17.4% | 16.9% | 16.0% | 17.4% |
| # Shareholders | 18,669 | 16,181 | 15,222 | 12,612 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.69 L Cr | 38.8 | 18.7% | 14.6% | 0.05 |
| DIVISLAB | 2.45 L Cr | 83.9 | 23.0% | 17.4% | 0.00 |
| TORNTPHARM | 1.89 L Cr | 79.4 | 15.1% | 25.7% | 1.76 |
| ZYDUSLIFE | 1.16 L Cr | 25.9 | 16.8% | 16.6% | 0.43 |
| CIPLA | 1.14 L Cr | 33.9 | 13.2% | 9.8% | 0.01 |
| LAURUSLABS | 1.03 L Cr | 94.1 | 20.8% | 20.6% | 0.45 |
| LUPIN | 99,585 | 17.6 | 27.9% | 24.7% | 0.26 |
| MANKIND | 99,078 | 48.5 | 13.9% | 12.7% | 0.38 |
| DRREDDY | 97,240 | 30.1 | 10.1% | 8.4% | 0.17 |
| AUROPHARMA | 97,239 | 26.4 | 12.8% | 9.8% | 0.20 |
🔗 Peer Stock Analyses
📋 Recent Filings
-
🔴 annual report 25 August 2026Amanta Healthcare Limited announced that shareholders who have not registered their email addresses with the company or its RTA can access the Annual ...
-
🔴 annual report 24 August 2026Amanta Healthcare Limited announced its 31st AGM on September 16, 2026, via video conferencing, with e-voting from September 13-15, 2026, and a cut-of...
-
Announcement 8 August 2026Amanta Healthcare reported Q1 FY27 revenue of INR69 crores, up 5% YoY with a stable 22% EBITDA margin, driven by SteriPort expansion and captive solar...
-
Announcement 8 August 2026Amanta Healthcare Limited disclosed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming compliance with SEBI regulations rega...
-
🔴 Financial Results 7 August 2026Amanta Healthcare Limited (AMANTA) announced on August 7, 2026, the publication of its unaudited financial results for the quarter ended June 30, 2026...
-
Announcement 6 August 2026Amanta Healthcare Limited announced the availability of an audio recording from its post-results conference call held on August 6, 2026, hosted on its...
-
Announcement 3 August 2026Amanta Healthcare Limited announced its Q1 FY27 earnings conference call scheduled for August 6, 2026 at 11:00 AM IST to discuss financial results and...
-
share transfer 10 July 2026Amanta Healthcare Limited received a SEBI-mandated certificate from MUFG Intime India confirming dematerialization of securities for the quarter ended...
-
🔴 Insider Trading 1 July 2026Amanta Healthcare Limited disclosed an off-market transfer of equity shares via Regulation 7(2) insider trading disclosures, with promoter Bhavesh Pat...
-
Announcement 29 June 2026Amanta Healthcare Limited announced a special window for transferring and dematerializing physical shares, as per SEBI Circular dated January 30, 2026...
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AMANTA files new disclosures
Track AMANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AMANTA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd